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The goal of this work is to advance the pro-
duction and use of 52Mn (t1/2=5.6 d, β
+: 242 keV, 
29.6%) as a radioisotope for in vivo preclinical 
nuclear imaging. More specifically, the aims of 
this study were: (1) to measure the excitation 
function for the natCr(p,n)52Mn reaction at low 
energies to verify past results [1-4]; (2) to meas-
ure binding constants of Mn(II) to aid the design 
of a method for isolation of Mn from an irradiat-
ed Cr target via ion-exchange chromatography, 
building upon  previously published methods 
[1,2,5-7]; and (3) to perform phantom imaging 
by positron emission tomography/magnetic 
resonance (PET/MR) imaging  with 52Mn and 
non-radioactive Mn(II), since Mn has potential 
dual-modality benefits that are beginning to be 
investigated [8]. 
 
Material and Methods 
Thin foils of Cr metal are not available 
commercially, so we fabricated these in a man-
ner similar to that reported by Tanaka and Fu-
rukawa [9]. natCr was electroplated onto Cu discs 
in an industrial-scale electroplating bath, and 
then the Cu backing was digested by nitric acid 
(HNO3). The remaining thin Cr discs (~1 cm di-
ameter) were weighed to determine their thick-
ness (~75-85 μm) and arranged into stacked foil 
targets, along with ~25 μm thick Cu monitor 
foils. These targets were bombarded with ~15 
MeV protons for 1-2 min. at ~1-2 μA from a CS-
15 cyclotron (The Cyclotron Corporation, Berke-
ley, CA, USA). The beamline was perpendicular 
to the foils, which were held in a machined 
6061-T6 aluminum alloy target holder. The tar-
get holder was mounted in a solid target station 
with front cooling by a jet of He gas and rear 
cooling by circulating chilled water (T≈2-5 °C). 
Following bombardment, these targets were 
disassembled and the radioisotope products in 
each foil were counted using a high-purity Ge 
(HPGe) detector. Cross-sections were calculated 
for the natCr(p,n)52Mn reaction. 
Binding constants of Mn(II) were measured 
by incubating 54Mn(II) (t1/2=312 d) dichloride 
with anion- or cation-exchange resin (AG 1-X8 
(Cl- form) or AG 50W-X8 (H+ form), respectively; 
both: 200-400 mesh; Bio-Rad, Hercules, CA) in 
hydrochloric acid (HCl) ranging from 10 mM-8 M 
(anion-exchange) and from 1 mM-1 M (cation-
exchange) or in sulfuric acid (H2SO4) ranging 
from 10 mM-8 M on cation-exchange resin only. 
The amount of unbound 54Mn(II) was measured 
using a gamma counter, and binding constants 
(KD) were calculated for the various concentra-
tions on both types of ion-exchange resin. 
We have used the unseparated product for 
preliminary PET and PET/MR imaging. natCr metal 
was bombarded and then digested in HCl, result-
ing in a solution of Cr(III)Cl3 and 
52Mn(II)Cl2. This 
solution was diluted and imaged in a glass scin-
tillation vial using a microPET (Siemens, Munich, 
Germany) small animal PET scanner. The signal 
was corrected for abundant cascade gamma-
radiation from 52Mn that could cause random 
false coincidence events to be detected, and 
then the image was reconstructed by filtered 
back-projection. Additionally, we have used the 
digested target to spike non-radioactive 
Mn(II)Cl2 solutions for simultaneous PET/MR 
phantom imaging using a Biograph mMR (Sie-
mens) clinical scanner. The phantom consisted 
of a 4x4 matrix of 15 mL conical tubes containing 
10 mL each of 0, 0.5, 1.0, and 2.0 mM concen-
trations of non-radioactive Mn(II)Cl2 with 0, 8, 
17, and 33 μCi (corrected to start of PET acquisi-
tion) of 52Mn(II)Cl2 from the digested target 
added. The concentrations were based on previ-
ous MR studies that measured spin-lattice relax-
ation time (T1) versus concentration of Mn(II), 
and the activities were based on calculations for 
predicted count rate in the scanner. The PET/MR 
imaging consisted of a series of two-dimensional 
inversion-recovery turbo spin echo (2D-IR-TSE) 
MR sequences (TE=12 ms; TR=3,000 ms) with a 
wide range of inversion times (TI) from 23-2,930 
ms with real-component acquisition, as well as a 
30 min. list-mode PET acquisition that was re-
constructed as one static frame by 3-D ordered 
subset expectation maximization (3D-OSEM). 
Attenuation correction was performed based on 
a two-point Dixon (2PD) MR sequence. The 
DICOM image files were loaded, co-registered, 
and windowed using the Inveon Research Work-
place software (Siemens). 
Results and Conclusion 
Cross-sections were measured for the 
natCr(p,n)52Mn reaction. The highest cross-
section measured was σ=0.15 b, which occurred 
at the highest energy measured of Ep=14.0 MeV. 
This is in agreement with previous work [1,4]. 
In the binding studies, 54Mn(II) bound quite 
effectively (KD>10
3 mL/g) to the cation-exchange 
resin at low concentrations of HCl (1, 10, 50 
mM), but its binding then decreased with higher 
concentration, reaching KD=1.2 mL/g at 3 M HCl. 
Similarly, the binding of 54Mn(II) to a cation-
exchange resin in H2SO4 was also high (KD>10
2) 
at lower acid concentrations (10 and 100 mM) 
and decreased with increasing H2SO4, reaching 
no measured binding at 3 and 8 M. With the 
anion-exchange resin, a slight trend suggested 
54Mn(II) bound more effectively to the anion-
exchange resin with increasing HCl, but the max-
imum value of KD=1.7 mL/g at 8 M HCl was very 
small. Additionally, we found that the presence 
of ethanol in HCl solutions significantly affected 
the binding of 54Mn(II) with either resin. 
Phantom PET and PET/MR imaging were 
performed, with the idea that non-radioactive 
Mn(II) would provide T1-shortening contrast in 
T1-weighted MRI and the 52Mn would provide 
PET signal. Figure 1 shows clearly the increased 
counts from PET as the activity of 52Mn added 
increased from top to bottom. It also shows 
decreasing MR signal as the concentration of 
cold Mn(II) increased from left to right. This 
occurs because TI (2,930 ms) for the MR in Fig-
ure 1 was long enough for the solutions with 
longer T1 (less Mn(II)) to relax to a more positive 
magnetization (brighter signal) compared to 
vials containing more Mn(II), shown in shades of 
gray that still show positive signal (gray=zero; 
black=negative). However, we also noticed that 
the MR signal decreases from top to bottom. We 
believe that this change in MR signal was not 
from the added 52Mn because its highest con-
centration in any vial was <2 nM, which would 
be difficult to detect by MRI. Based on the 
masses of the target foils, we estimate that the 
concentrations of Cr(III) from the dissolved tar-
get was many times the total concentration 
Mn(II): 0, 8, 16, and 33 mM. It appears that even 
though Cr(III) has a magnetic moment ~35% less 
than Mn(II), these high concentrations of Cr(III) 
have produced significant T1 shortening signal in 
the MR imaging. This MR artifact from Cr(III) 
supports the importance for effective separation 
of 52Mn. Future imaging of separated 52Mn 
product should have minimal effect on MR sig-
nals. 
In summary, we have produced thin natCr 
discs that were bombarded in stacked foil exper-
iments to measure cross-sections and to pro-
duce 52Mn for PET/MR imaging in a clinical scan-
ner. We have also performed ion-exchange bind-
ing experiments that will support ongoing work 
on separating 52Mn from a Cr target. Finally, we 
have conducted preliminary imaging studies 
investigating 52Mn as a PET agent that could be a 
tool for studying contrast agents for manganese-
enhanced MRI (MEMRI). 
 
 
FIGURE 1. PET/MR images of a phantom consisting of vials containing non-radioactive Mn(II) and un-
separated 52Mn(II) (with Cr(III)). PET: A 30 min. list-mode PET acquisition that was reconstructed as one 
static frame. Attenuation correction was performed by two-point Dixon sequence. (Radioactivity labels 
were corrected to the start of PET data acquisition.) MR: A two-dimensional inversion-recovery turbo spin 
echo MR sequence (TE=12 ms; TR=3,000 ms; TI 2,930 ms) with real-component acquisition. 
  
References 
1. M. Buchholz, I. Spahn, B. Scholten, H.H. Coenen: 
Radiochim. Acta, 101, pp. 491-499, 2013. 
2. A.T.J. Klein, F. Rosch, S.M. Qaim: Radiochim. 
Acta, 88, pp. 253-264, 2000. 
3. J.R. Walton, D. Heymann, A. Yaniv, D. Edgerley, 
M.W. Rowe: J. Geophys. Res., 81, pp. 5689-5699, 
1976. 
4. J.N. Barrandon, J.L. Debrun, A. Kohn, R.H. Spear: 
Nucl. Instr. Meth. 127, pp. 269-278, 1975. 
5. G.J. Topping, P. Schaffer, C. Hoehr, T.J. Ruth, V. 
Sossi: Med. Phys., 40, pp. 042502, 2013. 
6. S. Lahiri, D. Nayak, G. Korschinek: Anal. Chem, 
78, pp. 7517-7521, 2006. 
7. A.T.J. Klein, F. Rosch, H.H. Coenen, S.M. Qaim: 
Radiochim. Acta, 90, pp. 167-177, 2002. 
8. A.T.J. Klein, F. Rosch, H.H. Coenen, S.M. Qaim: 
Appl. Radiat. Isot., 62, pp. 711-720, 2005. 
9. S. Tanaka, M. Furukawa: J. Phys. Soc. Japan, 14, 
pp. 1269-1275, 1959. 
Acknowledgements 
The authors are grateful for valuable contri-
butions from the following core facilities at 
WUSM: the Cyclotron Facility, the Instrument 
Machine Shop, the Electronics Shop, the Small 
Animal Imaging Core, and the Center for Clinical 
Imaging Research, as well as from a local busi-
ness, Four Star Finishing (St. Louis). We also 
appreciate helpful advice from Tara E. Mastren 
and Xingyu Nie, both from the Lapi group. 
This work was funded in part by the Nation-
al Nuclear Security Administration, U.S. Depart-
ment of Energy (DE-NA0000979), and A.L.W. 
was funded in part by a training grant from the 
U.S. National Institutes of Health (1T32EB14855-
01). 
 
